These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 12115239)

  • 1. Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure.
    Cracowski JL; Carpentier PH; Imbert B; Cachot S; Stanke-Labesque F; Bessard J; Bessard G
    Arthritis Rheum; 2002 May; 46(5):1319-23. PubMed ID: 12115239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis.
    Cracowski JL; Kom GD; Salvat-Melis M; Renversez JC; McCord G; Boignard A; Carpentier PH; Schwedhelm E
    Free Radic Biol Med; 2006 May; 40(10):1732-7. PubMed ID: 16678012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders.
    Cracowski JL; Marpeau C; Carpentier PH; Imbert B; Hunt M; Stanke-Labesque F; Bessard G
    Arthritis Rheum; 2001 May; 44(5):1143-8. PubMed ID: 11352247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term treatment with vitamin E in systemic sclerosis: a double blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement.
    Cracowski JL; Girolet S; Imbert B; Seinturier C; Stanke-Labesque F; Bessard J; Boignard A; Bessard G; Carpentier PH
    Free Radic Biol Med; 2005 Jan; 38(1):98-103. PubMed ID: 15589377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders.
    Murray AK; Moore TL; Manning JB; Taylor C; Griffiths CE; Herrick AL
    Arthritis Rheum; 2009 Aug; 61(8):1103-11. PubMed ID: 19644893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local hyperemia to heating is impaired in secondary Raynaud's phenomenon.
    Boignard A; Salvat-Melis M; Carpentier PH; Minson CT; Grange L; Duc C; Sarrot-Reynauld F; Cracowski JL
    Arthritis Res Ther; 2005; 7(5):R1103-12. PubMed ID: 16207327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features.
    Volpe A; Biasi D; Caramaschi P; Mantovani W; Bambara LM; Canestrini S; Ferrari M; Poli G; Degan M; Carletto A; Pieropan S; Minuz P
    Rheumatology (Oxford); 2006 Mar; 45(3):314-20. PubMed ID: 16219641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of fingertip lacticemy before and after cold stimulus in patients with primary Raynaud's phenomenon and systemic sclerosis.
    Pucinelli ML; Fontenelle S; Andrade LE
    J Rheumatol; 2002 Jul; 29(7):1401-3. PubMed ID: 12136896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenon.
    Furspan PB; Mayes MD; Freedman RR
    J Rheumatol; 2001 Oct; 28(10):2263-8. PubMed ID: 11669167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury.
    Solans R; Motta C; Solá R; La Ville AE; Lima J; Simeón P; Montellà N; Armadans-Gil L; Fonollosa V; Vilardell M
    Arthritis Rheum; 2000 Apr; 43(4):894-900. PubMed ID: 10765936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased urinary F2-isoprostanes in patients with Crohn's disease.
    Cracowski JL; Bonaz B; Bessard G; Bessard J; Anglade C; Fournet J
    Am J Gastroenterol; 2002 Jan; 97(1):99-103. PubMed ID: 11808977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
    Furspan PB; Chatterjee S; Mayes MD; Freedman RR
    Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser doppler imaging--a new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis.
    Clark S; Campbell F; Moore T; Jayson MI; King TA; Herrick AL
    Microvasc Res; 1999 May; 57(3):284-91. PubMed ID: 10329254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
    Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
    Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.